Skip to main content

steroid 5 alpha-reductase 3

The SRD5A3 gene provides instructions for making an enzyme called steroid 5-alpha reductase 3. This enzyme performs a chemical reaction that converts a compound called polyprenol into another compound called dolichol. Subsequently, another enzyme converts dolichol to dolichol phosphate. The production of dolichol phosphate is critical for a process called glycosylation, by which small chains of sugar molecules (oligosaccharides) are attached to proteins. Glycosylation changes proteins in ways that are important for their functions.

Video picks for Genes
Video library

Normal function

The SRD5A3 gene provides instructions for making an enzyme called steroid 5-alpha reductase 3. This enzyme performs a chemical reaction that converts a compound called polyprenol into another compound called dolichol. Subsequently, another enzyme converts dolichol to dolichol phosphate. The production of dolichol phosphate is critical for a process called glycosylation, by which small chains of sugar molecules (oligosaccharides) are attached to proteins. Glycosylation changes proteins in ways that are important for their functions.

Dolichol phosphate is integral for the formation of the sugar chains that are attached to proteins during glycosylation. Individual sugars are added to dolichol phosphate to build the oligosaccharide chain. Once the chain is formed, it is transferred from dolichol phosphate to a specific site on the protein that needs to be glycosylated.

Conditions referring to this gene or chromosome

Other names

FLJ13352

SRD5A2L

SRD5A2L1

Patient picks for Genes

Related patient information and medicines

Enlarged prostate

Patient information leaflet

Enlarged prostate

See the separate leaflets called. There are two groups of medicines that may help: Alpha-blockers. 5-alpha reductase inhibitors. Alpha-blocker medicines Alpha-blockers. These medicines work by relaxing the sm... This can improve the flow of urine. 5-alpha reductase inhibitor medicines. These are alternatives to alpha-blockers. These work by.

Prostate problems

Patient information leaflet

Prostate problems

This leaflet will... There are various treatments for the symptoms of BPH, including drugs such as alfuzosin/doxazosin (alpha-blockers), dutasteride/finasteride (5-alpha reductase inhibitors), oxybutinin/tolterodine/fesoterodine/darifenacin/solifenacin/trospium (antimuscarinics), mirabegron (for overactive bladder) and desmopressin (for frequent.

Blood in semen

Patient information leaflet

Blood in semen

Haematospermia means there is blood in the semen. The haematospermia itself does not need any treatment. Medicines If you have persistent haematospermia without an identified cause then a type of medicine called a 5-alpha reductase inhibitor such as finasteride Finasteride for prostate gland enlargement or dutasteride Dutasteride for prostate.

Crohn's disease

Patient information leaflet

Crohn's disease

Crohn's disease is a lifelong condition with flare-ups from time to time. If symp... A course of steroids (corticosteroids) Steroid medicines Oral steroids work by reducing inflammation and are usually used first-line for those who are newly diagnosed or who have no more than one flare-up per year. The two commonly used steroids for Crohn's.

Psoriatic arthritis

Patient information leaflet

Psoriatic arthritis

Surgery is sometimes needed if a joint or tendon becomes badly damaged. What is psoriatic arthritis. It probably occurs because the tissue which covers tendons is similar to the synovium around the joints. A commo... Codeine Codeine for pain relief is another painkiller that is sometimes used. Steroids An injection of steroid Steroid injections.

Ankylosing spondylitis

Patient information leaflet

Ankylosing spondylitis

The type of inflammation in AS ca... Ankylosing spondylitis is an auto-immune disease. It is not known exactly why ankylosing spondylitis occurs but there is a genetic predisposition. 6 out of 100 people who have a particular gene variant called HLA-B27 have ankylosing spondylitis whereas it is thought that it affects fewer than 1 in 100 people.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 24 Sept 2021 | Latest version
  • 1 Sept 2021 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.